glaucoma
Conditions
Interventions
Retrospective study of patients:none
Prospective study of patients:none
Sponsors
Changsha Aier Eye Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: (1) Patients in prospective studies: a. The patient voluntarily participates in this study, signs the informed consent form, and agrees to be followed up in accordance with the research plan; b. Glaucoma patients undergoing mTLT include but are not limited to primary open-angle glaucoma, primary angle-closure glaucoma, secondary glaucoma, neovascular glaucoma, intraocular pressure failure to decrease after anti-glaucoma surgery, etc. (2) Patients in retrospective study: a. Patients who received mTLT treatment in our hospital since September 2022 but were not included in prospective follow-up, including but not limited to primary open-angle glaucoma, primary angle-closure glaucoma, secondary glaucoma, neovascular glaucoma, and anti-glaucoma Intraocular pressure does not decrease after surgery.
Exclusion criteria
Exclusion criteria: Prospective study: a. Combined with active eye inflammation, such as acute conjunctivitis, acute uveitis, etc.; b. Combined with a history of serious systemic diseases: diabetes, hypertension (systolic blood pressure = 160mmHg or diastolic blood pressure = 100mmHg), heart disease, kidney disease, rheumatic immunity, digestive system diseases, tumors, etc.; c. Pregnant or lactating women, and patients younger than 18 years old. Retrospective study: patients whose postoperative review time in our hospital was less than 1 month.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| intraocular pressure; | — |
Secondary
| Measure | Time frame |
|---|---|
| Postoperative complications;The number of intraocular pressure lowering drugs used; | — |
Countries
China
Contacts
Public ContactXuanchu Duan
Changsha Aier Eye Hospital
Outcome results
None listed